Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: Involvement of SOCS3 and SOCS1

Journal of Leukocyte Biology

Volumn 78, Issue 4, 2005, Pages 1008-1015

  Zhuang, Dazhong ^a   Qiu, Yaling ^a   Hague, S Jaharul ^b   Dong, Fan ^a  

^a UNIVERSITY OF TOLEDO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Granulopoiesis; Signal transduction

Indexed keywords

AMIDE; CYCLOHEXAMIDE; DACTINOMYCIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLALANINE; PROTEIN KINASE B; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE; STAT4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TYROSINE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; GRANULOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL LINE; HUMANS; MICE; MUTATION; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYROSINE;

EID: 25644444568     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0105032     Document Type: Article

References (41)

1. Demetri, G. D., Griffin, J. D. (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808.
2. Avalos, B. R. (1996) Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88, 761-777.
3. Akbarzadeh, S., Layton, J. E. (2001) Granulocyte colony-stimulating factor receptor: structure and function. Vitam. Horm. 63, 159-194.
4. McLemore, M. L., Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J., Link, D. C. (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204.
5. de Koning, J. P., Soede-Bobok, A. A., Ward, A. C., Schelen, A. M., Antonissen, C., van Leeuwen, D., Lowenberg, B., Touw, I. P. (2000) STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene 19, 3290-3298.
6. Lee, C. K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R. A., Levy, D. E. (2002) STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72.
7. Dong, F., Liu, X., de Koning, J. P., Touw, I. P., Hennighausen, L., Lamer, A., Grimley, P. M. (1998) Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J. Immunol. 161, 6503-6509.
8. Ilaria, R. L. J., Hawley, R. G., Van Etten, R. A. (1999) Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93, 4154-4166.
9. Teglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., Ihle, J. N. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850.
10. Ilaria, R. L. J., Van Etten, R. A. (1996) P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271, 31704-31710.
11. Sillaber, C., Gesbert, F., Frank, D. A., Sattler, M., Griffin, J. D. (2000) STATS activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood 95, 2118-2125.
12. Ho, J. M., Beattie, B. K., Squire, J. A., Frank, D. A., Barber, D. L. (1999) Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood 93, 4354-4364.
13. Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Muller, C., Gruning, W., Kratz-Albers, K., Serve, S., Steur, C., Buchner, T., Kienast, J., Kanakura, Y., Berdel, W. E., Serve, H. (2000) Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood 96, 3907-3914.
14. Onishi, M., Nosaka, T., Misawa, K., Mui, A. L., Gorman, D., McMahon, M., Miyajima, A., Kitamura, T. (1998) Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871-3879.
15. Dong, F., Brynes, R. K., Tidow, N., Weite, K., Lowenberg, B., Touw, I. P. (1995) Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333, 487-493.
16. Dong, F., Dale, D. C., Bonilla, M. A., Freedman, M., Fasth, A., Neijens, H. J., Palmblad, J., Briars, G. L., Carlsson, G., Veerman, A. J., Welte, K., Lowenberg, B., Touw, I. P. (1997) Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11, 120-125.
17. Tidow, N., Pilz, C., Teichmann, B., Muller-Brechlin, A., Germeshausen, M., Kasper, B., Rauprich, P., Sykora, K. W., Welte, K. (1997) Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 89, 2369-2375.
18. Aprikyan, A. A., Kutyavin, T., Stein, S., Aprikian, P., Rodger, E., Liles, W. C., Boxer, L. A., Dale, D. C. (2003) Cellular and molecular abnormalities in severe congenital neutropenia. Exp. Hematol. 31, 372-381.
19. Dong, F., van Buitenen, C., Pouwels, K., Hoefsloot, L. H., Lowenberg, B., Touw, I. P. (1993) Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol. Cell. Biol. 13, 7774-7781.
20. Hermans, M. H., Antonissen, C., Ward, A. C., Mayen, A. E., Ploemacher, R. E., Touw, I. P. (1999) Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J. Exp. Med. 189, 683-692.
21. Dong, F., Qiu, Y., Yi, T., Touw, I. P., Larner, A. C. (2001) The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J. Immunol. 167, 6447-6452.
22. Ward, A. C., Oomen, S. P., Smith, L., Gits, J., van Leeuwen, D., Soede-Bobok, A. A., Erpelinck-Verschueren, C. A., Yi, T., Touw, I. P. (2000) The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia 14, 1284-1291.
23. de Koning, J. P., Soede-Bobok, A. A., Schelen, A. M., Smith, L., van Leeuwen, D., Santini, V., Burgering, B. M., Bos, J. L., Lowenberg, B., Touw, I. P. (1998) Proliferation signaling and activation of She, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91, 1924-1933.
24. Haque, S. J., Harbor, P. C., Williams, B. R. (2000) Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J. Biol Chem. 275, 26500-26506.
25. Dong, F., Gutkind, J. S., Larner, A. C. (2001) Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. J. Biol. Chem. 276, 10811-10816.
26. de Koning, J. P., Schelen, A. M., Dong, F., van Buitenen, C., Burgering, B. M., Bos, J. L., Lowenberg, B., Touw, I. P. (1996) Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood 87, 132-140.
27. Akbarzadeh, S., Ward, A. C., McPhee, D. O., Alexander, W. S., Lieschke, G. J., Layton, J. E. (2002) Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells. Blood 99, 879-887.
28. Smithgall, T. E., Briggs, S. D., Schreiner, S., Lerner, E. C., Cheng, H., Wilson, M. B. (2000) Control of myeloid differentiation and survival by Stats. Oncogene 19, 2612-2618.
29. Battle, T. E., Frank, D. A. (2002) The role of STATs in apoptosis. Curr. Mol. Med. 2, 381-392.
30. Datta, S. R., Brunet, A., Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
31. Vivanco, I., Sawyers, C. L. (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
32. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362.
33. Hilton, D. J. (1999) Negative regulators of cytokine signal transduction. Cell. Mol. Life Sci. 55, 1568-1577.
34. Krebs, D. L., Hilton, D. J. (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19, 378-387.
35. Hortner, M., Nielsch, U., Mayr, L. M., Johnston, J. A., Heinrich, P. C., Haan, S. (2002) Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J. Immunol. 169, 1219-1227.
36. van de Geijn, G. J., Gits, J., Aarts, L. H., Heijmans-Antonissen, C., Touw, I. P. (2004) G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 104, 667-674.
37. van de Geijn, G. J., Gits, J., Touw, I. P. (2004) Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J. Leukoc. Biol. 76, 237-244.
38. Dong, F., Larner, A. C. (2000) Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 95, 1656-1662.
39. Hunter, M. G., Avalos, B. R. (2000) Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 95, 2132-2137.
40. Hunter, M. G., Jacob, A., O'Donnell, L. C., Agler, A., Druhan, L. J., Coggeshall, K. M., Avalos, B. R. (2004) Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J. Immunol. 173, 5036-5045.
41. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., Yoshimura, A. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320.